TY - JOUR
T1 - Cross-Sectional Study of Arterial Stiffness in Adolescents with Down Syndrome
AU - Kelly, Andrea
AU - Magge, Sheela N.
AU - Walega, Rachel
AU - Cochrane, Claire
AU - Pipan, Mary E.
AU - Zemel, Babette S.
AU - Cohen, Meryl S.
AU - Gidding, Samuel S.
AU - Townsend, Ray
N1 - Funding Information:
Supported by the National Institutes of Health (NIH) (R01HD071981 [to A.K. and S.M.]), NIH National Center for Research Resources and the National Center for Advancing Translational Sciences (UL1TR000003, UL1TR001876), and Research Electronic Data Capture (REDCap). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest. Supported by the National Institutes of Health (NIH) (R01HD071981 [to A.K. and S.M.]), NIH National Center for Research Resources and the National Center for Advancing Translational Sciences (UL1TR000003, UL1TR001876), and Research Electronic Data Capture (REDCap). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/9
Y1 - 2019/9
N2 - Objectives: To test whether youth with Down syndrome have aortic stiffness indices, as measured by pulse wave velocity (PWV), that differ from youth without Down syndrome and to compare reference-based age-adjusted (age-PWV-Z) and height-adjusted (Ht-PWV-Z) in youth with and without Down syndrome. Study design: Cross-sectional study of PWV in 129 adolescents with Down syndrome and 97 youth of comparable age, sex, race/ethnicity, and body mass index (BMI). PWV, age-PWV-Z, and Ht-PWV-Z were compared. Regression models were developed to test for associations with PWV. Results: Youth with Down syndrome and controls were comparable in BMI-Z (1.4 [−1.5 to 2.8] vs 1.2 [−2.0 to 2.8], P = .57) but not Ht-Z (−2.3 [−4.7 to 0.8] vs 0.4 [−2.0 to 2.6], P < .0001). PWV (m/s, 5.0 [3.1-7.9] vs 5.0 [3.6-8.0], P = .5) and mean arterial pressure (MAP, mm Hg) (78 [61-102] vs 74 [64-97], P = .09) were not different between groups. In adjusted analyses confined to Down syndrome, PWV was associated only with BMI, but not age, black race, or MAP (R2 = 0.11). In contrast, BMI, age, black race, and MAP were all positively associated with and better explained PWV in controls (R2 = 0.50). PWV was not associated with height in youth with or without Down syndrome. Although age-PWV-Z was not different in Down syndrome (−0.36 [−2.93 to 3.49]) vs −0.15 [−2.32 to 3.22]), Ht-PWV-Z was greater in Down syndrome (0.32 [−2.28 to 4.07] vs −0.08 [−2.64 to 2.64], P = .002), and Ht-PWV-Z was greater than age-PWV-Z in Down syndrome (P < .0001). Conclusions: The lack of relationship of PWV, an independent predictor of adult cardiovascular events, with its traditional determinants including MAP suggests Down syndrome−specific phenomena may alter such relationships in this population. In youth with Down syndrome, Ht-adjusted PWV may overestimate aortic stiffness. Trial Registration: Clinicaltrials.gov: NCT01821300.
AB - Objectives: To test whether youth with Down syndrome have aortic stiffness indices, as measured by pulse wave velocity (PWV), that differ from youth without Down syndrome and to compare reference-based age-adjusted (age-PWV-Z) and height-adjusted (Ht-PWV-Z) in youth with and without Down syndrome. Study design: Cross-sectional study of PWV in 129 adolescents with Down syndrome and 97 youth of comparable age, sex, race/ethnicity, and body mass index (BMI). PWV, age-PWV-Z, and Ht-PWV-Z were compared. Regression models were developed to test for associations with PWV. Results: Youth with Down syndrome and controls were comparable in BMI-Z (1.4 [−1.5 to 2.8] vs 1.2 [−2.0 to 2.8], P = .57) but not Ht-Z (−2.3 [−4.7 to 0.8] vs 0.4 [−2.0 to 2.6], P < .0001). PWV (m/s, 5.0 [3.1-7.9] vs 5.0 [3.6-8.0], P = .5) and mean arterial pressure (MAP, mm Hg) (78 [61-102] vs 74 [64-97], P = .09) were not different between groups. In adjusted analyses confined to Down syndrome, PWV was associated only with BMI, but not age, black race, or MAP (R2 = 0.11). In contrast, BMI, age, black race, and MAP were all positively associated with and better explained PWV in controls (R2 = 0.50). PWV was not associated with height in youth with or without Down syndrome. Although age-PWV-Z was not different in Down syndrome (−0.36 [−2.93 to 3.49]) vs −0.15 [−2.32 to 3.22]), Ht-PWV-Z was greater in Down syndrome (0.32 [−2.28 to 4.07] vs −0.08 [−2.64 to 2.64], P = .002), and Ht-PWV-Z was greater than age-PWV-Z in Down syndrome (P < .0001). Conclusions: The lack of relationship of PWV, an independent predictor of adult cardiovascular events, with its traditional determinants including MAP suggests Down syndrome−specific phenomena may alter such relationships in this population. In youth with Down syndrome, Ht-adjusted PWV may overestimate aortic stiffness. Trial Registration: Clinicaltrials.gov: NCT01821300.
KW - Down syndrome
KW - cardiovascular disease
KW - obesity
KW - pulse-wave velocity
UR - http://www.scopus.com/inward/record.url?scp=85066922092&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066922092&partnerID=8YFLogxK
U2 - 10.1016/j.jpeds.2019.04.059
DO - 10.1016/j.jpeds.2019.04.059
M3 - Article
C2 - 31201031
AN - SCOPUS:85066922092
SN - 0022-3476
VL - 212
SP - 79-86.e1
JO - Journal of Pediatrics
JF - Journal of Pediatrics
ER -